quantitative
Analysis v1
35
Pro
0
Against

If you use sunscreen lotion instead of a spray, more of the active chemicals get into your bloodstream—so lotions might leave more oxybenzone and avobenzone in your body than sprays do.

Evidence Quality Assessment

Claim Status

appropriately stated

Study Design Support

Design supports claim

Appropriate Language Strength

probability

Can suggest probability/likelihood

Assessment Explanation

The claim is based on measurable pharmacokinetic data from human studies comparing absorption across formulations. While multiple studies (e.g., FDA 2019, JAMA) have shown higher plasma levels with lotions, the magnitude of difference can vary by application amount, skin area, and individual metabolism. The use of 'generally' reflects natural variability, making 'probability' the correct verb strength. A definitive claim would overstate consistency across all individuals and conditions.

More Accurate Statement

Sunscreen lotions tend to produce higher plasma concentrations of oxybenzone and avobenzone than spray formulations, based on current human pharmacokinetic studies.

Context Details

Domain

medicine

Population

human

Subject

Different sunscreen formulations (lotion, aerosol spray, nonaerosol spray, pump spray)

Action

result in

Target

varying plasma concentrations of active ingredients (oxybenzone and avobenzone), with lotion generally producing higher levels than sprays

Intervention Details

Type: topical sunscreen application

Gold Standard Evidence Needed

According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.

Evidence from Studies

Supporting (1)

35

Contradicting (0)

0
No contradicting evidence found